Advertisement

Topics

Flupenthixol Decanoate in Methamphetamine Smoking - 1

2014-08-27 04:00:15 | BioPortfolio

Summary

The purpose of this study is to evaluate the safety and efficacy of flupenthixol decanoate for treatment of methamphetamine dependence. Also, study will compare flupenthixol with desipramine in blocking methamphetamine self-administration.

Study Design

Primary Purpose: Treatment

Conditions

Substance-Related Disorders

Intervention

Flupenthixol

Location

Friends Research Institute
Los Angeles
California
United States
90025

Status

Completed

Source

National Institute on Drug Abuse (NIDA)

Results (where available)

View Results

Links

Published on BioPortfolio: 2014-08-27T04:00:15-0400

Clinical Trials [943 Associated Clinical Trials listed on BioPortfolio]

Infusion Laboratory: Protocol 5 (Flupenthixol) - 14

The purpose of this study is to evaluate clinical safety issues pertaining to flupenthixol, to cocaine, and to their interaction, and to determine how pretreatment with flupenthixol modifi...

Flupenthixol Treatment in Schizophrenic Cocaine Abusers - 1

The purpose of this study is to evaluate the safety and efficacy of flupenthixol for cocaine dependence in individuals with schizophrenia/schizoaffective illness.

Women's Treatment for Trauma and Substance Use Disorders - 1

The purpose of this study is to compare the effectiveness of adding Seeking Safety to standard substance abuse treatment to adding a control condition: Women's Health Education to standard...

Integrated Intervention for Substance Abusers With Depressive Disorders

This study is a randomized clinical trial comparing outcomes of Integrated Cognitive Behavioral Treatment plus standard medications for veterans with both substance use disorders, depressi...

Treatment Adherence in Substance Users

This study evaluates the factors associated with treatment adherence in substance users. Differences in the level of adherence to treatment according to patient-related factors, addiction ...

PubMed Articles [14489 Associated PubMed Articles listed on BioPortfolio]

The associations between psychotic experiences, and substance use and substance use disorders: Findings from the World Health Organisation World Mental Health Surveys.

Prior research has found bidirectional associations between psychotic experiences (PEs), and selected substance use disorders. We aimed to extend this research by examining the bidirectional associati...

Change in anxiety sensitivity and substance use coping motives as putative mediators of treatment efficacy among substance users.

Anxiety sensitivity and coping motives for substance use are processes implicated in anxiety and substance use disorder (SUD) comorbidity, and are malleable treatment targets. Little is known about wh...

Effects of anxiety and mood disorders on craving and substance use among patients with substance use disorder: An ecological momentary assessment study.

Despite recognition of the negative impact of psychiatric comorbidity on addictive disorders, the mechanisms underlying this association remain poorly understood. The present investigation applied mob...

Depression and smoking characteristics among HIV-positive smokers in Russia: A cross-sectional study.

Globally, persons with HIV infection, depression and substance use disorders have a higher smoking prevalence and smoke more heavily than other populations. These associations have not been explored a...

Problem and Pathological Gambling in Schizophrenia: Exploring Links with Substance Use and Impulsivity.

High rates of both problem and pathological gambling (PPG) and substance-use disorders (SUDs) have been reported in schizophrenia, and yet PPG frequently goes undetected in clinical practice and unexa...

Medical and Biotech [MESH] Definitions

Disorders related to substance abuse, the side effects of a medication, toxin exposure, and ALCOHOL-RELATED DISORDERS.

These disorders are related to both SCHIZOPHRENIA SPECTRUM AND RELATED DISORDERS and DEPRESSIVE DISORDERS in terms of symptomatology, family history, and genetics. (DSM-V) .

Psychotic organic mental disorders resulting from the toxic effect of drugs and chemicals or other harmful substance.

Disorders related or resulting from abuse or mis-use of opioids.

Disorders related or resulting from use of amphetamines.

More From BioPortfolio on "Flupenthixol Decanoate in Methamphetamine Smoking - 1"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Searches Linking to this Trial